# A Study to Assess the PK of AL-794 Formulations in Healthy Subjects

> **NCT02877160** · PHASE1 · COMPLETED · sponsor: **Alios Biopharma Inc.** · enrollment: 31 (actual)

## Conditions studied

- Influenza

## Interventions

- **DRUG:** AL-794 suspension
- **DRUG:** AL-794 tablet

## Key facts

- **NCT ID:** NCT02877160
- **Lead sponsor:** Alios Biopharma Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-30
- **Primary completion:** 2017-02-28
- **Final completion:** 2017-05-31
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2017-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02877160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02877160, "A Study to Assess the PK of AL-794 Formulations in Healthy Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02877160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*